Investor Relations NASDAQ: MDWD Website Notice Block Press Releases Year: - Any -20192018201720162015201420132012 Items per page 102550 Date Title and Summary View Toggle SummarySeptember 23, 2012 Positive Recommendation for Marketing Authorization from the European Medicines Agency for its innovative drug – NexoBrid™ NexoBrid™ has shown statistically significant effect in earlier eschar removal from burn wounds and reduction in the number and extent of surgical excision and autografting View HTML Positive Recommendation for Marketing Authorization from the European Medicines Agency for its innovative drug – NexoBrid™ 13.9 KB Pagination First page First Previous page Previous … Page 12 Page 13 Page 14 Current page 15
Press Releases Year: - Any -20192018201720162015201420132012 Items per page 102550 Date Title and Summary View Toggle SummarySeptember 23, 2012 Positive Recommendation for Marketing Authorization from the European Medicines Agency for its innovative drug – NexoBrid™ NexoBrid™ has shown statistically significant effect in earlier eschar removal from burn wounds and reduction in the number and extent of surgical excision and autografting View HTML Positive Recommendation for Marketing Authorization from the European Medicines Agency for its innovative drug – NexoBrid™ 13.9 KB Pagination First page First Previous page Previous … Page 12 Page 13 Page 14 Current page 15
Positive Recommendation for Marketing Authorization from the European Medicines Agency for its innovative drug – NexoBrid™ 13.9 KB
